Benefits and Harms of Sodium-Glucose Co-Transporter 2 Inhibitors in Patients with Type 2 Diabetes: A Systematic Review and Meta-Analysis
Heidi Storgaard(University of Copenhagen), Tina Vilsbøll(University of Copenhagen)
Cited by 241
Related Papers
Incretins, insulin secretion and Type 2 diabetes mellitus
|Diabetologia|2004|438
Semaglutide, reduction in glycated haemoglobin and the risk of diabetic retinopathy
|Diabetes Obesity and Metabolism|2017|290